文献速递免疫规划慢病防控与筛查

全血培养中CD4high记忆细胞增殖可定量VZV细胞免疫

Quantification of a cell-mediated immune response against varicella zoster virus by assessing responder CD4high memory cell proliferation in activated whole blood cultures.
PubMed 文献 · Vaccine · 2019-07-26

研究开发了一种全血培养结合流式细胞术的方法,通过检测VZV抗原刺激后CD3+CD4highCD45RA-RO+记忆细胞增殖来量化VZV细胞免疫。样本包括32名儿童、18名年轻成人和80名有水痘史的老年人,老年组接种VZV疫苗后2个月和1年采血。结果显示CD4high-M增殖在免疫情儿童中可检出,年轻成人高于老年人,疫苗接种后2个月增强并维持至少1年。

要点

  • 全血培养9天流式检测CD4high-M增殖可量化VZV细胞免疫。
  • CD4high-M细胞呈CCR7-效应记忆表型且颗粒酶B阳性。
  • 老年人接种VZV疫苗后2个月CD4high-M增殖升高并维持1年。

核心结论

  • 量化VZV反应性CD4high-M细胞增殖是一种用小血量测量VZV细胞免疫的便捷方法。
  • 该方法可用于测量老年人VZV疫苗诱导的细胞免疫。

研究设计与样本

  • 研究采集32名2-15岁有或无天花感染史儿童、18名28-45岁年轻成人和80名50-86岁有水痘史老年人的血样。
  • 老年组接种VZV疫苗,并在接种后2个月和1年采血。
  • 1 mL全血与VZV混合,培养基稀释1/10后培养,用流式细胞术鉴定和测量CD4-M细胞。

主要发现

  • 培养第9天检测到VZV抗原特异性CD3+CD4highCD45RA-RO+(CD4high-M)细胞明显增殖。
  • 多数CD4high-M细胞为CCR7-效应记忆表型且颗粒酶B阳性。
  • 有水痘免疫的儿童血培养可检出CD4high-M细胞,无水痘免疫儿童未检出。
  • 年轻成人CD4high-M增殖水平高于老年人。
  • 老年人接种VZV疫苗后2个月CD4high-M增殖水平升高,并至少维持1年。

临床怎么用

  • 可采用小血量全血培养9天流式检测CD4high-M增殖评估VZV细胞免疫。
  • 该方法适用于监测老年人接种VZV疫苗后的细胞免疫应答。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Herpes zoster (HZ) is caused by reactivation of a latent varicella zoster virus (VZV). The potential to develop HZ increases with age due to waning of memory cell-mediated immunity (CMI), mainly the CD4 response. Therefore, VZV-CD4-memory T cells (CD4-M) count in blood could serve as a barometer for HZ protection. However, direct quantification of these cells is known to be difficult because they are few in number in the blood. We thus developed a method to measure the proliferation level of CD4-M cells responding to VZV antigen in whole blood culture. METHODS: Blood samples were collected from 32 children (2-15 years old) with or without a history of varicella infection, 18 young adults (28-45 years old), and 80 elderly (50-86 years old) with a history of varicella infection. The elderly group was vaccinated, and blood samples were taken 2 months and 1 year after VZV vaccination. Then, 1 mL of blood was mixed with VZV, diluted 1/10 in medium, and cultured. CD4-M cells were identified and measured by flow cytometry. RESULTS: There was distinct proliferation of CD3+CD4highCD45RA-RO+ (CD4high-M) cells specific to VZV antigen at day 9. The majority of CD4high-M cells had the effector memory phenotype CCR7- and was granzyme B-positive. CD4high-M cells were detected in blood culture from varicella-immune but not varicella-non-immune children. Meanwhile, a higher level of CD4high-M proliferation was observed in young adults than in the elderly. The CD4high-M proliferation level was boosted 2 months after VZV vaccination and maintained for at least 1 year in the elderly. CONCLUSION: Quantifying VZV responder CD4high -M cell proliferation is a convenient way to measure VZV CMI using small blood volumes. Our method can be applied to measure VZV vaccine-induced CMI in the elderly. Clinical study registry numbers: (www.clinicaltrials.jp) 173532 and 183985.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Haredy AM, Takei M, Iwamoto SI, et al. Quantification of a cell-mediated immune response against varicella zoster virus by assessing responder CD4high memory cell proliferation in activated whole blood cultures. Vaccine. 2019. PMID: 31358406. doi:10.1016/j.vaccine.2019.07.068

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。